Non-Invasive Treatment System for Psychiatric Disorders ID: 2012-007
A revolutionary non-pharmacological approach to treating psychiatric disorders by enhancing dopamine release using whole-head light stimulation.
Photo by Shisu_ka - stock.adobe.com
Technology Overview
This innovative system developed at Brigham Young University offers a non-invasive method to increase dopamine transmission in the limbic system of rodents, with potential applications for humans. Unlike traditional treatments that rely on pharmacological interventions or electrical stimulation, this technology uses light to stimulate dopamine release, aiming to address various psychiatric disorders associated with low dopamine levels, including drug addiction.
Key Advantages
- Non-invasive and non-pharmacological, reducing potential side effects
- Targets the limbic system to directly enhance dopamine release
- Offers a novel approach to treating dopamine-associated psychiatric disorders
- Potential to significantly reduce relapse rates in drug addiction
- Developed with federal support, indicating a strong scientific foundation
Problems Addressed
- Dependency on pharmacological treatments for psychiatric disorders
- High relapse rates in drug addiction recovery
- Limited effectiveness and side effects of current treatments for low dopamine disorders
Market Applications
- Clinics and hospitals specializing in psychiatric care
- Rehabilitation centers for drug addiction
- Research institutions studying dopamine-related disorders
- Development of home-based treatment devices for patients
Additional Information
Technology ID: 2012-007
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 30 June, 2025
Connect with the Tech Transfer to:
- Meet with the technology manager
- Receive additional information
- Request a marketing plan report